Javascript must be enabled to continue!
Comparison of flexible, open with semi-rigid, closed annuloplasty-rings for mitral valve repair
View through CrossRef
Abstract
Background
Mitral regurgitation is a frequent valvular disease, with an increasing prevalence. We analysed the long-term outcomes of mitral valve repair procedures conducted over the last 10 years in our clinic using almost exclusively two different annuloplasty ring types.
Methods
A single-centre, retrospective analysis of mitral valve surgeries conducted between January 2005 and December 2015 for patients undergoing first-line mitral valve repair with either open (Cosgrove) or closed (CE Physio / Physio II) annuloplasty (OA or CA, respectively) rings.
Results
In total, 1120 patient documentations were available of which 528 underwent OA and 592 patients CA. The median age of patients was 64.0 years and 41.1% were female. The majority of these patients underwent the procedure because of degenerative valve disease. Rates of successful repair were about 90%, 72 h procedural mortality was 0.6% and the rate of re-intervention was 0.6% within the first 30 days. Functional (mitral regurgitation, left ventricular ejection fraction, left ventricular end-diastolic and systolic diameter and New York Heart Association class) as well as hard outcomes were comparable. 77.7 and 74.4% of patients were alive at the 10-year follow-up in the OA and CA groups, respectively. Upon multivariable adjustment, the hazard ratio was 0.926 (95% CI: 0.642–1.3135; p = 0.681).
Conclusions
The functional outcome and survival rates up to 10 years after mitral valve repair were comparable using open and closed annuloplasty rings. Whether this means these rings are interchangeable or a carefully selection of the best-for-the-patient devices will be subject of future investigations.
Springer Science and Business Media LLC
Title: Comparison of flexible, open with semi-rigid, closed annuloplasty-rings for mitral valve repair
Description:
Abstract
Background
Mitral regurgitation is a frequent valvular disease, with an increasing prevalence.
We analysed the long-term outcomes of mitral valve repair procedures conducted over the last 10 years in our clinic using almost exclusively two different annuloplasty ring types.
Methods
A single-centre, retrospective analysis of mitral valve surgeries conducted between January 2005 and December 2015 for patients undergoing first-line mitral valve repair with either open (Cosgrove) or closed (CE Physio / Physio II) annuloplasty (OA or CA, respectively) rings.
Results
In total, 1120 patient documentations were available of which 528 underwent OA and 592 patients CA.
The median age of patients was 64.
0 years and 41.
1% were female.
The majority of these patients underwent the procedure because of degenerative valve disease.
Rates of successful repair were about 90%, 72 h procedural mortality was 0.
6% and the rate of re-intervention was 0.
6% within the first 30 days.
Functional (mitral regurgitation, left ventricular ejection fraction, left ventricular end-diastolic and systolic diameter and New York Heart Association class) as well as hard outcomes were comparable.
77.
7 and 74.
4% of patients were alive at the 10-year follow-up in the OA and CA groups, respectively.
Upon multivariable adjustment, the hazard ratio was 0.
926 (95% CI: 0.
642–1.
3135; p = 0.
681).
Conclusions
The functional outcome and survival rates up to 10 years after mitral valve repair were comparable using open and closed annuloplasty rings.
Whether this means these rings are interchangeable or a carefully selection of the best-for-the-patient devices will be subject of future investigations.
Related Results
Midterm Results of Mitral Valve Repair for Atrial Functional Mitral Regurgitation: A Retrospective Study
Midterm Results of Mitral Valve Repair for Atrial Functional Mitral Regurgitation: A Retrospective Study
Abstract
Background: Annular dilation by left atrial remodeling is considered the main cause of atrial function mitral regurgitation. Although acceptable outcomes have been...
Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease
Recurrence of Mitral Valve Regurgitation After Mitral Valve Repair in Degenerative Valve Disease
Background—
Durability assessment of mitral valve repair for degenerative valve incompetence is actually limited to reoperation as the primary indicator, w...
Ischemic mitral regurgitation: mitral valve replacement, restrictive annuloplasty or multi-component reconstruction with subvalvular intervention (systematic review and meta-analysis)
Ischemic mitral regurgitation: mitral valve replacement, restrictive annuloplasty or multi-component reconstruction with subvalvular intervention (systematic review and meta-analysis)
Objective: The study is aimed at assessing short- and long-term results of various strategies of surgical treatment in patients with ischemic mitral insufficiency.
Methods: The stu...
The New Era of Three-Dimensional Annuloplasty Devices for Mitral Valve Repair: Rationale and First Experiences
The New Era of Three-Dimensional Annuloplasty Devices for Mitral Valve Repair: Rationale and First Experiences
Annuloplasty should always accompany mitral valve repair in order to achieve proper annular remodeling and stabilization. Numerous types of annuloplasty rings—that differ from rig...
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Mitral valve disease is a common heart disease in dogs. The aim of this study was to describe the cases of dogs who underwent mitral valve repair using a v-clamp device and to prov...
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Transcatheter Edge-to-Edge Repair of the Mitral Valve in Four Dogs
Mitral valve disease is a common heart disease in dogs. The aim of this study was to describe the cases of dogs who underwent mitral valve repair using a v-clamp device and to prov...
Modulation of Transforming Growth Factor-β Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers
Modulation of Transforming Growth Factor-β Signaling and Extracellular Matrix Production in Myxomatous Mitral Valves by Angiotensin II Receptor Blockers
Background—
Little is known about the pathophysiology of myxomatous degeneration of the mitral valve, the pathological hallmark of mitral valve prolapse, associated wit...
Early results of mitral vavle repair of degenerative mitral valve regurgitation
Early results of mitral vavle repair of degenerative mitral valve regurgitation
Background: Mitral valve regurgitation due to degenerative valve disease is a common disease affecting about 2% of the population, mainly in developed countries [2],[6]. Medical t...

